final quiz Flashcards

final quiz studying

1
Q

Seven rules of vaccination:

A

The more similar a vaccine is to the natural disease, the better the immune response to the vaccine.

Circulating antibody has more effect on the immune response to live attenuated vaccines than on the immune response to inactivated vaccines.

All vaccines can be administered at the same visit as all other vaccines.

Live attenuated vaccines generally produce long-lasting immunity with one or two doses. Inactivated vaccines generally require three or more doses and may require periodic boosting to maintain immunity.

Increasing the interval between doses of a multidose vaccine does not diminish the effectiveness of the vaccine. Decreasing the interval between doses of a multidose vaccine may interfere with the antibody response and protection.

Adverse reactions following live attenuated vaccines are similar to a mild form of the natural disease. Adverse reactions following inactivated vaccines are mostly local, and may occur with or without fever.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

two permanent contraindications to vaccination

A

Severe allergic reaction to a vaccine component or following a prior dose of vaccine. (Do not give another dose of that vaccine.) Encephalopathy without a known cause occurring within 7 days of a dose of a pertussis-containing vaccine. (Do not give another dose of a pertussis-containing vaccine.)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Temporary Contraindications to Vaccines

A
  • Pregnancy (live)
  • Moderate/severe illness (all)
  • Immunosuppression (live)
  • Antibody containing products (live)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Influenza

A

annually for life, two types of vaccine available – inactivated influenza vaccines (TIV) IM and live attenuated influenza vaccine (LAIV) intranasally.

Can use intranasal LAIV if less than 50, healthy, non pregnant and not high risk.

Over 65 use standard seasonal or high dose.

OK for women in their second/third trimester.

Do not give to those on chemotherapy, not within three days of pertussis vaccine, not during febrile illness, if using LAIV do not administer when nasal congestion is present.

LAIV should not be given to pts with chronic pulmonary, cardiovascular, renal, hepatic, neurologic/neuromuscular, hematologic or metabolic disorders, immune suppression, HIV/AIDs, children up to 18 years old receiving aspirin or other salicylates, or pregnant women.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

TD/Tdap

A

Tetanus, diphtheria, pertussis - first dose to infants with boosters before age of 2. Then booster Td every 10 years for life substituting 1 Td booster with Tdap in adulthood (12, 22, 32, etc.)

All pregnant women receive Tdap regardless of history.

Uncertain history – give 3 dose primary series of Td with Tdap as one of the doses.

Adults 65 and older in close contact with children 12 months and younger, who have not already received Tdap or whose pertussis status is unknown SHOULD get single dose Tdap. All adults 65 and over MAY get single dose Tdap.

In wounds, if no completion of series may require passive immunity with Human TIG especially if wound is contaminated with soil containing animal excreta.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Varicella Vaccine

A

contains cell-free live attenuated varicella-zoster virus.

Breakthrough disease is common about 42 days or longer after vaccination.

When immunized in early childhood, a single dose is very effective, with an age related decreased in effectiveness.

All adults who do not have evidence of immunity should receive 2 doses 4 weeks apart. Pregnant women should be immunized if no immunity evidence once the child has been born but before leaving the hospital.

Special considerations to HCP, family contacts of persons with immune compromise and those at high risk for exposure or transmission

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Zoster vaccination

A

live attenuated form of the varicella-zoster virus approved for use in adults older than 60, it is the same as the varicella vaccine but contains 14 fold higher concentration of the strain.

It prevents zoster in 50% of recipients and prevents neuralgia in 2/3 of the recipients.

Do not give to severely immune compromised patients (AIDS, immunosuppressive TX, corticosteroid use, ALL, active TB, blood dyscrasias, bone marrow malignancy and lymph malignancy. Hold dose if received IGG treatment in the last 5 months.

Do not give to pt with Hx of anaphylaxis to neomycin.

Contraindicated in those with anaphylactic reaction to gelatin, neomycin or any other component.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

MMR

A

a live attenuated vaccine,

All children receive this at 12-15 months with a booster at 6years.

Adult health care workers without history of vaccination or evidence of immunity should received 2 doses.

severely immune compromised ppl should avoid,

pts on high dose oral corticosteroids should wait 1 month after cessation to be vaccinated, women should wait 1 mos after vaccination to get pregnant,

if receiving IgG must wait 3 months after end to get MMR,

TB skin test should postpone until 4-6 wks after MMR.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

HPV vaccine

A

HPV4 (6,11,16,18) and HPV 2 (6,18).

HPV2 not indicated for males.

Gardasil given to both males and females. Cervarix only for females.

administer 3 doses after age 11 and before age 26 in women, through age 21 unless not previously immunized in males

Could be given as young as 9 yrs old

MSM between 21-26 years.

Second dose should be administered 1-2 months after first, the third dose should be 6 months only longer after the first.

Do not administer to pregnant women, ok for lactation, ok for immune compromised.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Pneumococcal

A

PPSV23 (pneumovax) is polyvalent mixture from the 23 most prevalent or invasive types. Recommended for all adults over 64, and for those 2- 64 years who have a chronic medical problem, immune suppression, or immunosuppressive therapyl smoker, asthma, or resident of a LTC or SN facility.

If first given before age 65, give one dose at age 65 or 5 years after first dose, whichever is later. No booster after age 65. Max 2 doses per lifetime.

PCV13 (Prevnar 13) was approved for use in children up to 10 years, should also be used in adults older than 19 with immune compromise, cochlear implants, CSF leaks or asplenia. In these adults never previously immunized, PCV13 is given and then followed by PPSV23 no sooner than 8 weeks later.

If previously immunized adult, if received PPSV23, then give PCV13 1 year after most recent dose. For those needing more PPSV23, it should not be administered until 8 weeks after PCV13 and 5 years after most recent PPSV23 dose.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Meningococcal vaccine

A

MCV4 (Menactra) Single dose should be administered at 11 years or prior to high school. Anyone at risk for meningococcal dz should be immunized – including college dorm living, military recruits, living in endemic areas, asplenia, or complement component deficiency.

MCV4 for age 55 and under. MPSV4 (Menomune) for those older than 55 years.

Do not use in patients with Hx of Gillian Barre!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Hepatitis A vaccine

A

administer routinely to children older than 1 year, with a second dose given 6-12 months later. Indicated for high risk individuals: IVDU, MSM, HIV, high risk work settings, those at risk for fulminant liver disease , recipients of clotting factors, HCPs, or those travelling to areas endemic.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Hepatitis B vaccine

A

Recommended for all infants, and children if not administered in infancy.

Adult with the following conditions should be vaccinated: diabetes, chronic liver disease, ESRD, household contact or sexual partner of HBV +, high risk individuals HIV, MSM, prisoners, IVDU, etc. individuals who receive blood products, hemodialysis patients, residents and staff of LTC and correctional Institutions, and immigrants/adoptees/family members where it is endemic. Some travel indication. Health care personnel and public safety staff

Under 20 dose at 0.5ml, over 20 dose at 1ml IM, 3 total doses, 2nd dose 1-2 mos after 1st, 3rd within 6 mos of 1st dose.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Polio vaccine

A

an inactivated, killed virus (IPV) given as .5ml IM, initial series should be done in early childhood. Offers lifetime immunity.

Should be offered to adults who travel to endemic areas, for lab workers handling virus, or healthcare workers in close contact with patients.

IPV dose can be given to adults who previously received OPV (oral polio virus – administered orally not in the states)

Avoid giving to pregnant women unless immediate protection is needed.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Rabies vaccine

A

give to those at high risk for animal bites, given as a series and started immediately after any bite. Rabies immunoglobulin gives passive protection when started after exposure to rabies.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Yellow fever

A

a live attenuated virus preparation which gives 10 years immunity for travelers and lab personnel with exposure risk.

Do not give to children younger than 9 months, do not give during pregnancy unless high risk of exposure.Do not give to those with immune disorders.

Avoid during lactation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Typhoid vaccine

A

live attenuated product taken orally (Ty21a) or polysaccharide prep IM (ViCPS).

Give to those travelling to areas where endemic, India, Middle East and central Africa, those who expect contact with infected individuals, and in lab workers who handle it.

Do not give oral formulation to immunocompromised individuals.

Antimalarial drug proquanil should not be stared until 10 days after the oral dose.

Do not administer during acute gastroenteritis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Primary prevention

A

is the promotion of well being and is targeted toward the well population. In primary prevention we are trying to prevent a person’s development of risk. This is the classic health promotion phase. Education on both an individual and community basis is key.

EG flouride treatments, folic aacid, immunizations, legal drinking age, condoms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Secondary prevention

A

is the early intervention phase, targeting those at risk or who have developed risk of illness. Interventions that occur when there is already disease but before there are symptoms, such as in pap, colonoscopy and mammography screening. In this phase we are trying to prevent progression to established disease and hospitalization/chronic management/acute processes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Tertiary prevention

A

is essentially disease management. A person has an established disease, is rehabilitating to restore or maximize function, or is in continuing care for disease management. Goals include prevention for complications, reduction of disability. (ie support groups, chronic pain management, PT)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Positive predictive value

A

the proportion of people with a positive test result who have the target disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Negative predictive value

A

the proportion of people with a negative test result who do not have the target disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Prostate CA screening

A

second leading cause of cancer death in men over 50. PSA has a poor balance of specificity and sensitivity, identifies trends well.

Screen starting at age 50 for those without risk factors.

Discuss starting at 45 years for those that are African American or first degree relative with prostate CA before age 65, if multiple first degree relatives with Dx start at age 40.

Combine PSA and DRE in screening conversation.

Focus on prevention – maintain healthy weight, 30 min of vigorous exercise 5 or more times a week, eat at least 5 servings of vegies and fruits, 3 servings of whole grains, cut back on red meats, especially processed ones. Red flags include difficulty starting stream, erectile dysfunction.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Colorectal CA screening

A

Start at age 50 and stop at 75 if low risk

Start at age 40 if high risk.

Risk factors include personal history of cancer or polyps, strong family history, personal history of chronic inflammatory bowled dz, familial adenomatous polyposis, hereditary non-polyposis colon CA in family, African American, Ashkenazi Jews. If IBD, start 8-10 years after dz.

fecal occult blood test (FOBT) and fecal immunochemical test (FIT) every year, and

stool DNA test (sDNA) at uncertain interval. Colonoscopy should be done for any positive.

FOBT and FIT should be conducted with take home multiple sample. Do not do in office with rectal exam.

OR Tests that find polyps and cancer include flexible sigmoidoscopy (every 5 years), colonoscopy every 10 years, double contrast barium enema every 5 years, or CT colonography every 5 years.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Lung CA screening

A

low dose helical CT for high risk patients only = age 55-74, 30 pack years smoking, asymptomatic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Diabetes screening

A

start at age 45 if no risk factors,

stat at any age with BMI 25kg/m or over + one more risk factor,

if tests are normal, repeat testing at 3 year intervals.

Screen with fasting glucose, 2 hr glucose tolerance test or HbA1C. OGTT may be considered in patients with IFG (impaired fasting glucose) to better define risk.

Medicare will pay for a max of 2 screening tests in a 12 mo time period for pre-diabetics, only once for non-diabetics not previously diagnosed with DM.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Diabetes Diagnosis

A

HbA1C ≥ 6.5%,

fasting plasma glucose (FPG) ≥ 126,

2 hr glucose ≥ 200 during 75g glucose tolerance test,

or if pt has symptoms of hyper or hypoglycemia, random plasma glucose ≥ 200.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

gestational diabetes

A

screen at first prenatal visit for those at risk or in 24-28 weeks of gestation using OGTT, women with GDM should cont screening 6-12 weeks postpartum (10% will get postpartum DM).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Impaired glucose tolerance (IGT)

A

by oral glucose tolerance test 140 – 199mg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Impaired fasting glucose (IFG)

A

FBG 110 to 125

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

High risk to develop DM type 2

A

IFG or IGT with one or more risk factors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Metabolic Syndrome

A

At least 3 of the following:

  • Large waist – 40 inches or larger for men, 35 inches or larger for women
  • High TGs – 150 or higher, or on treatment to reduce
  • Low HDL – less than 50
  • Hypertension – BP 130/85 or higher, or on treatment
  • Hyperglycemia – fasting blood sugar of 100 or higher or on antihyperglycemics (about 85% of ppl with DM 2 have metabolic syndrome)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Treat Metabolic Syndrome

A
  1. Healthy lifestyle changes,
  2. Medications for BP, blood sugar, lipids,
  3. Blood thinning medications
  4. Heart healthy diet, increase physical activity, quit smoking
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Modifiable risk factors for CVD

A
  • Smoking
  • Obesity
  • Physical inactivity
  • Diet
  • ETOH
  • Diabetes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

Stages of change

A
  1. Pre-contemplation
  2. Contemplation
  3. Preparation
  4. Action
  5. Maintenance
  6. Relapse
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

LDL Goals

A

are determined by cigarette smoking, hypertension, Low HDL, Age >45 men or >55 women, family history of premature CHD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

DASH Diet

A

“Dietary Approaches to Stop Hypertension” A combination diet that lowers blood pressure. It is rich in fruits veggies and low fat dairy foods, and low in saturated and total fat. Low in cholesterol and high in dietary fiber, potassium, calcium, and magnesium, and moderately high in protein. Based on a 2000 calorie a day need

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

Obesity – strategies for losing wt, and maintaining wt loss

A
  • eating foods that help in losing weight
  • recording foods eaten
  • refusing food offered by others
  • being able to stop eating when appropriate.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

Mature Minor Rule

A

a minor may consent to receive medical care without the consent of the parents or guardian if deemed mature by the judicial system. In some states consent to care is based on the type of care the adolescent is seeking. Maternity services, contraceptive management, treatment and diagnosis of STDS, treatment od rug or alcohol problems and care related to sexual assault or mental health services may be independent.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

Emancipation:

A

legal process in which a person under 1 petitions to have herself declared a legal adult, ending the parents duty to support, and right to make decisions.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

Chlamydia

A

can infect the urethra and cervix can cause pain with urination or lower abdominal pain, can spread to tubes and ovaries, in men can infect urethra and epididymis, causing pain with urination, swelling and pain of the testicles. Spread by body fluids! treat with Abx and treat the partners

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

bacterial STDs

A

chlamydia, Gonorrhea, Syphilis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

viral STDs

A

Herpes- HSV I and II, painful ulcers, or sometimes no symptoms

Hepatitis B - MSM at higher risk

Mollluscum Contagiousum – pimple like lesions often confused with acne or folliculitis

HIV

HPV - over 100 types of HPV virus, 20 cause warts or cancer, treat warts with patient applied creams aldara or condylox. Or freeze with liquid nitrogen, caustic chemicals or laser. PAPs detect if reflexive order – yearly pap if ever abnormal or HPV.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

Cardiovascular Causes of Sudden Death in Young Athletes

A
  • Hypertrophic cardiomyopathy
  • Coronary artery anomalies
  • Commotio cordis (i.e., blunt trauma to the chest causing ventricular fibrillation)
  • Left ventricular hypertrophy
  • Myocarditis
  • Marfan syndrome (i.e., aortic root dilatation, aneurysm and subsequent rupture)
  • Arrhythmogenic right ventricular cardiomyopathy
  • Tunneled coronary artery
  • Aortic stenosis
  • Dilated cardiomyopathy
  • Myxomatous mitral valve degeneration
  • Mitral valve prolapse
  • Drug abuse
  • Long QT syndrome
  • Cardiac sarcoidosis
  • Brugada syndrome (a genetic disorder of myocardial sodium ion channels)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

questions for the pre participation physical

A

Have you ever passed out or nearly passed out during or after exercise?

Have you ever had discomfort, pain, or pressure in your chest during exercise?

Does your heart race or skip beats during exercise?

Has a doctor ever told you that you have high blood pressure, high cholesterol, a heart murmur, or a heart infection?

Has a doctor ever ordered a test for your heart (e.g., electrocardiography, echocardiography)?

Has anyone in your family died for no apparent reason?

Does anyone in your family have a heart problem?

Has anyone in your family died of heart problems or of sudden death before 50 years of age?

Does anyone in your family have Marfan syndrome?

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

Emergency contraception

A

Progestin only emergency contraception

Levonorgestrel 0.75 PO 12 hours apart Single dose 1.5 mg

Prevents ovulation, prevents fertilization, does not disrupt any events that have occurred after fertilization

Must be used within 72 hours of event

Teens should be given a prescription

Some OCPs can be double dosed to effectively act as EC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
47
Q

scoliosis treatment

A

observation, bracing and surgery

Observation is the preferred for curves at low risk of further progression, and where the natural history is favorable (curves less than 20 degrees, or curves under 40 degrees after the child has reached skeletal maturity)

Bracing for curves with documented progression and where the child has not reached skeletal maturity. These curves are at risk for progression, and the goal of the bracing is to stop this progression.

Surgical treatment is reserved for curves which are out of balance or those in excess of 50 degrees.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
48
Q

Missed 1 OCP

A

take as soon as possible no backup needed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
49
Q

Missed 2 Pills in Week 1 or 2

A

Take 2 pills for 2 days and finish package

use backup for 7 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
50
Q

Missed 2 Pills in Week 3

A

Sunday starters take 1 pill every day until Sunday then start new pack

Day 1 starter throw away rest of the pack and start a new pack on the same day

Use backup for 7 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
51
Q

Missed 3 or more pills anytime

A

Sunday starters take 1 pill every day until Sunday then start new pack

Day 1 starter throw away rest of the pack and start a new pack on the same day

Use backup for 7 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
52
Q

Geriatric functional assessments

A

Katx, index (dressing, bathing, toilet, transfer, feeding, continence)

Brthel index

Lawton IADL – prepare meals, housework, laudry, do you take Rx, go places beyond walking distance, shopping for groceries?

Functional Activities Questionaire – 5 sections, physical function of ADLs, phsychological function, role function, social function, variety of performance measures

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
53
Q

Geriatric Cognitive Assessments

A

MMSE, minicog, clock drawing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
54
Q

osteoporosis prevention

A
  • Calcium/Vit D supplementation
  • Fruits and veggies
  • Weight bearing exercises and muscle strengthening
  • Measuring height annually
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
55
Q

Frax scores indicating treatment

A

> 3% risk hip fracture

>20% for any major osteo r/t fracture

56
Q

Get Up and Go Test

A

seated, stand without using hands, walk 10 feet, than turn around, walk back to chair and sit. If stanindg takes over 12 – 14 seconds, at risk for falls. If takes over 30 seconds then the person requires an assistive device, ar risk needing help with ADLs, Post op Hip Fx at discharge takes over 24 seconds, at risk for falls within 6 months

57
Q

30 Second Chair Stand

A

ist in middle straight back chair, place hands on opposite shoulder crossed at wrists, keep feet flat on floor, keep back straight and arms against chest, on “go” rise to a full standing position and then sit back down again, repeat for 30 seconds. Score 0 if uses hands, record # of times to stand in 30 seconds

58
Q

FOBT (fecal occult blood test) in elders based on life expectancy

A

>5yrs - yearly

<2yrs - do not perform

59
Q

Influenza vaccine in elders based on life expectancy

A

yearly for all

60
Q

Colonoscopy in elders based on life expectancy

A

>5yrs - every 5-10 yrs and

<2yrs - NO

61
Q

Cholesterol screening in elders based on life expectancy

A

>5yrs up to age 75 if additional risk fx - consider offering

<2yrs - NO

62
Q

Falls Prevention

A
  • Using MI/Stages of Change make suggestions
  • Educate that many falls can be prevented
  • Refer PT – increase leg strength, improve balance, use of walker
  • Medication adjustments
  • Consider reduce dose Lisinopril or Metoprolol or Furosemide and consider taper off Clonazepam
  • Refer podiatry – exam, customized foot wear
  • Add 1000 IU vitamin D – optimize muscle strength
  • Check b12 level-?deficiency as cause of decreased LE sensation
  • Refer eye- to fix glasses
  • Home modifications
  • remove tripping hazards, grab bars for tub, toilet
63
Q

HPV co-test

A

cytology + HPV test administered together

64
Q

Cervical Cancer Screening Age 21-30

A

Start at age 21 Screen every 3 years between age 21 and 30 Use cytology only, do not test for HPV because HPV usually clears within a few years

Screen more frequently if high risk, which includes HIV+ (at Dx test Q6mos x2, then annually if abnormal), immunosuppression, exposed to DES (diethylstilbestrol) in uetero or have been treated for high grade precancerous cervical lesion or cervical cancer.

65
Q

Cervical Cancer Screening Age 30-65

A

If low risk do co-testing every 5 years

If no HPV testing available do cytology every 3 years

Screen more frequently if history of abnormal cytology or at high risk (HIV, immunosuppression, DES in utero, hx of treatment for high grade precancerous cervical lesion or cervical cancer)

66
Q

NILM pap result

A

Negative for intraepithelial lesion and malignancy

67
Q

what to do if pap is unsatisfactory for eval

A

Scanty cellularity, obscuring inflammation or blood, unlabeled – repeat in 2 to 4 months

68
Q

how to manage • Insufficient/absent endocervical cells –with nilm

A
  • low risk and HPV negative routine screening
  • age 21-29 routine screening
  • Age 30 and over – get HPV testing if positive: repeat one year
69
Q

ASC-US

A

Atypical squamous cells – undetermined significance

  • Ideally get HPV testing
  • Use algorithm, depends on age, HPV status
70
Q

ASC–H (cannot exclude high-grade squamous intraepithelial lesion)

A
  • LGSIL – low grade
  • HGSIL – high grade
  • Use algorithm – follow up varies by age, pregnancy status, HPV status
71
Q

HGSIL

A

colposcopy and may need endocervical curetage (ECC) or loop electrosurgical excision (LEEP)

72
Q

Managing Normal Cytology with HPV+ >30 years

A

High risk HPV – genotype 16 and 18

If High risk HPV and NILM – refer to colposcopy

if HPV type not high risk – repeat pap and HPV in 12 months

*If unable to do genotyping can repeat in 12 months, if still HPV positive or with ASC or higher refer for colposcopy

73
Q

Preconception screening for inherited disorders

A

tay sachs (Ashkenazi jews, French canadiens and Cajuns), sickle cell, cystic fibrosis (caucasions, Ashkenazi jews), alpha thalassemia, and beta thalassemia (chinese, SE Asians, india, north africa, middle eastern, mediterrania).

74
Q

Screen for inherited disorder only if

A

The disorder is very debilitating or lethal.

A reliable screening test is available.

The fetus can be treated, or reproductive options (abortion / elective sterilization) are available and acceptable to the parents.

75
Q

BRCA1 and BRCA 2 genes

A

Occurs in 1 in 800 women and 1 in 40 women of Ashkenazy jewish descent

80% of lifetime risk breast CA and 50 risk ovaraion CA

a pattern of breast and ovarian CA in multiple relatives, or first degree relative with premenopausal cancer merits referral for counseling

76
Q

Breast CA risk factors

A
  • Aging
  • Family history of breast cancer
  • Presence of genetic mutations (BRCA1, BRCA2)
  • Early menarche
  • Late menopause
  • Nulliparity
  • Absence of history of breast feeding
  • Birth of first child after age 30
  • HRT postmenopausal
  • Ionizing radiation exposure
  • Post menopausal obesity
  • Alcohol intake – 2 to 5 drinks a day= 1.5 times risk of non drinker
77
Q

Breast CA genetic counseling referral

A

Refer if at least one first degree member has breast CA or score of 1.66% or greater on the Gail Model

78
Q

Breast CA screening for pt with above average risk

A
  • CBE annually starting no later than ten years earlier than the age at which the youngest family member was diagnosed with breast cancer
  • Annual mammography starting ten years prior to the age of the youngest family member with breast cancer (but not earlier than age 25 and not later than age 40)
  • Consider annual MRI, recommended if risk GT 20%
  • Consider staggering mammo/MRI/CBE
  • Women should be aware of any changes in their breasts. Monthly breast self-examination beginning at 20 years old is optional.
  • In general refer to breast specialist if high risk
79
Q

Ovarian CA risk factors

A

Risk factors;

Age>50years

BRCCA1 and BRCA2 genes

Family history in first degree relative

Postmenopausal estrogen use

80
Q

Ovarian CA screening and symptoms

A

*no effective screening exists.

Pelvic US for adnexal masses, CA125 tumor marker for postmenopausal women with adnexal mass or for relapse detection, consider annual transvaginal pelvic US with CA125 in high risk post menopausal women

Sx include bloating, pelvic or abdominal pain, difficulty eating or feeling full quicklu, urinary symtomps (urgency/frequency).

81
Q

Major Depression Disorder

A

4 or more of the following for 2 consecutive weeks:

  • Sleep – insomnia or hypersomnia
  • Interests – diminished interest and pleasure in activities
  • Guilt – excessive, inappropriate, feelings or worthlessness •Energy – loss or energy or fatigue
  • Concentration – diminished or indecisiveness
  • Appetite – change, wt loss/gain
  • Suicide – recurrent thoughts death, suicide, or attempts
82
Q

OCP warning signs

A

“ACHES”

  • Abdominal pain
  • Chest pain
  • Headaches
  • Eye Problems
  • Severe Leg Pain
83
Q

Risk factors for COPD

A
  • Alpha 1 antitrypisn deficiency
  • Tobacco exposure, occupational exposure, pollution
  • Gender (mortality is higher in men than women)
  • Age
  • respiratory infections
  • Socieconomic status
84
Q

COPD diagnosis

A

PFTs of FEB1/FVC ratio less than 0.70 is diagnostic. Order diagnositcs in all pts with chronic cough, chronic sputum, dyspnea, or inhalaltion exposure.

GOLD Classification based on PFTs:

Stage I: Mild- FEV1 GT 80% – cough and sputum production, individual usually unaware

Stage 2: Moderate –FEV1 50 to 80% - shortness of breath with exertion

Stage 3: Severe – FEV1 30 to 50 %- exacerbations, increased sob Stage

4: Very Severe- FEV1 LT 30% -chronic respiratory failure, quality of life very impaired

85
Q

5 As of smoking cessation

A
  • Ask – Ask about smoking at every visit
  • Advise – Clear, strong and personalized
  • Assess – Willing to quit? If yes, have a quit date? If no, see 5 R’s or do motivational interviewing
  • Assist – Facilitate counseling and medication
  • Arrange – Follow up contact
86
Q

Smoking Counseling the 5 R’s

A
  • Relevance- Establish why smoking may be significant to specific disease or family situation
  • Risks-Help pt articulate possible health specific consequences of smoking, eg risk to family members
  • Rewards-Visualize potential benefits of quitting – cost savings, improved sense of taste, improved appearance, role model for children
  • Roadblocks- identify obstacles, strategize for overcoming them
  • Repetition- Repeat motivational interventions with subsequent visits. Emphasize many fail before they eventually succeed.
87
Q

smoking cessation treatment options

A
  • Bupropion SR – BID dosing, avoid in sz do, alcholoics, start 1-3wks before quit date, use up to 6 months for relapse prevention, NRT ok, causes dry mouth
  • Nicotine gum, inhaler, lozenge, nasal spray
  • Nicotine patch – take off at night (nightmares and sweating, btw neck and waist, rotate sites, use high dose patch if >2ppd, safe in stable CVD
  • Varenicline – start 1 week before quit, lowest dose and titrate slowly, use for 12 weeks, psychiatric risks, suicide, changes in mode and behavior and CV events are major risks, do not use with NRT, main side effect nausea and sleep disturbance •Combined: nicotine patch + other nicotine
  • Combined: contact + support + medications
88
Q

Definition of moderate drinking

A

Moderate drinking: two or fewer drinks a day for men, one or fewer drinks a day for women, over age 65 = less than 7 drinks per week

89
Q

Heavy risk drinking

A

more than 14 drinks per week or more than 4 drinks per occasion for men,

more than 7 drinks per week or more than 3 drinks per occasion for woman

One drink = 0.6 oz of pure ETOH = 12 oz beer/wine cooler = 8oz malt liquor = 5 oz wine = 1.5oz 80 proof spirits

90
Q

Combined CAGE and Alcohol Use Disorder Identification Test

A
  • Do you ever feel the need to Cut back on your drinking?
  • Do you ever feel Angry when people ask you about your drinking habits?
  • Do you feel Guilty when you drink?
  • Do you ever have an Eye-opener in the morning?
  • How often do you have a drink containing alcohol?
  • How many drinks containing alcohol do you have on a typical day when you are drinking?
  • How often do you have five or more drinks on one occasion?
91
Q

Treating ETOH abuse

A

assist and recommend quit/cut down, relating medical condition and negotiate a drinking goal.

Refer to addiction specialist, AA, involve the SO.

May need medical withdrawal – detox – disulfiram, altexone, acomprosate.

Treat comorbid depression, thiamine, MVI and folic acid supplements.

Use GGT for diagnosis and monitoring.

92
Q

Benign Prostatic Hypertrophy – BPH Symptoms

A

Symptoms: by Voiding and Storage categories

Voiding – dribbling at the end of urination, urinary retention, dysuria, hematuria, hesitancy, difficulty initiating stream, straining to urinate, weak urine stream

Storage: urinary urgency, urgency incontinence, nocturia, urinary frequency

Diagnostics – medical history (DM, drugs, faml Hx, trauma), DRE, stricture, urethral discharge, Labs (creatinine, UA, urine cx, PSA, urine cytology, GC, chlamydia for r/o prostatitis), post void residual, cystoscopy, pressure flow studies.

93
Q

Non Rx Mgmt of BPH

A

urinate at first urge, void when you have the chance, avoid ETOH and caffeine, drink small amounts of fluid through the day, avoid OTC decongestant, antihistamines and anticholinergics, keep warm, prerform kegels, reduce stress

94
Q

Rx treatment for BPH

A

Alpha 1 adrenergic antagonists – immediate relief -terazosin, doxzosin, tamsulosin , alfuzosin, silodosin

5-alpha reductase inhibitors –long term treatment - finasteride , dutasteride

Combination of above – severe symptoms

Antimuscarinics – for obstructive symptoms

Beta-sitosterol – plant extract – likely effective (Promis Activ)

Pygeum – plum tree bark extract – likely effective

Saw palmetto – conflicting studies, possibly effective

Surgery – TURP, TUIP, prostatectomy

95
Q

Risk factors for Erectile Dysfunction

A

DM, metabolic syndrome, CVD (HTN, CHD, lipidemia), ETOH, obesity, smoking, sedentary lifestyle, depression, neurologic damage, pelvic or vascular surgery, BPH and some medications. It’s a marker for CVD!

96
Q

Erectile Dysfunction Assessment

A

PE – include pulses, neurovascular, perianal, GU and prostate Labs – TSH, AST, ALT, PSA, If low libido, consider testosterone levels

97
Q

ED treatment

A

Treatment – lifestyle changes, behavioral modification, oral agents, vacuum devices, surgery, prosthesis

98
Q

AAA risk factors

A

age >60, male gender, family history, smoking. Other risk factors include Caucasian, atherosclerosis, PVD, HTN, aneurysms of femoral or popliteal arteries.

99
Q

AAA screening

A

One time screening with abdominal ultrasound in two specific groups only:

  • Men ages 65 to 75 who have ever smoked*
  • Men ages 65 to 75 who have never smoked but who have a first degree relative who required AAA repair or who died from AAA rupture

Consider screening:

  • Men ages 55 to 75 with family history
  • Women ages 55 to 75 with family history
100
Q

Aortic Diameter Follow-up

A

Less than 3 cm – normal, none needed

3-3.9 cm – rescreen every 2 to 3 years

4-5.4 cm – rescreen every 6 months

5.5 cm and over – refer for surgery

101
Q

PSA lab considerations (things that alter the value)

A

Elevated PSA caused by BPH,

acute prostatitis (6-8 wks),

prostate biopsy (2 wks),

ejaculation (48 hours),

TURP,

urinary retention (2 wks)

perineal trauma (48 hours) (ie bike riding)

102
Q

PSA Result interpretation and management

A
  • Consider testing less frequently if PSA less than 1.0
  • Abnormal DRE or PSA over 7 – refer for further evaluation, eg transrectal ultrasound, biopsy
  • PSA 2.5 or 3 to 7 – repeat in a few weeks: no ejaculation, DRE, bike riding for at least 48 hours prior to test
  • Check for symptoms – get ua prn hematuria or gu sx, consider treat with antibiotics if indications of prostatitis
  • Watchful waiting, sequential PSA testing, referral …
103
Q

Anal Cancer Risk Factors

A

HPV infection, multiple sex partners, receptive anal intercourse (esp before age 30), smoking, immunosuppression, HIV, cervical/vulvar cancer, SP pelvic radiation treatment

104
Q

Anal Cancer Screening

A

Screen MSM regardless of HIV status, women with cervical cancer, high grade vulvar SIL or vulvar cancer, HIV positive men and women regardless of sexual orientation, and transplant recipients. Frequency of testing is uncertain.

Annually in HIV positive MSM, every 2 to 3 years in HIV negative MSM

105
Q

Anal Cancer Screening Method

A

Anal pap smear – exfoliative cytology

Avoid anal sex, douching, enemas prior to procedure

Left lateral position

Insert water moistened Dacron swab, until reaches rectal wall, withdraw in spiral motion with lateral pressure

Fix as per pap – Thin Prep or with ethanol

Self collection is an option

106
Q

Anal PAP Result Classification

A

Anal squamous intraepithelial lesions (ASIL)

ASC-US (abnormal squamous cells – undetermined significance) ASC-H (high grade)

LSIL (low grade SIL)

HSIL (high grade SIL)

Any degree of ASIL – needs high resolution anoscopy with acetic acid

107
Q

Testicular Cancer

A

Most common sold malignancy in males aged 15-35, more common in right testis, an undescended testicle has an increased risk (10-40x) of malignancy. 95% are germ cell tumors, either seminoma 35% or nonseminomatous germ cell tumors (NSGCT). 5% are non-germinla cell tumours and are usually benign

108
Q

Types of non-germinal cell testicular tumors

A

Ledyig – testosterone, precocious puberty. Sertoli – gynecomastica, decreased libido

109
Q

Signs and Symptoms of Testicular Cancer

A

painless testicular enlargement, painful if intrastesticular hemorrhage or infarction, firm, non tender mass, dull, heavy ache in the lower abdomen, anal area or scrotum, 10% have an associated hydrocele. Coincidental trauma is present 10% of the time. Lymph nodes will be palpable in the supraclavicular and inguinal areas.

110
Q

Testicular Cancer diagnostics

A

testicular ultrasound! (a high suspicion finding is hypoechoic area within the tunica albuginea).

Other diagnostics if nec. Chest xray (to check for lung metastasis), markers for staging including BhCG, AFP and LDH, CT of abdomen/pelvis if retroperitoneal nodes enlarged.

No needle aspiration!

111
Q

risk factors for HPV

A

early onset of sexual intercourse, multiple partners, HPV infection, tobacco use.

112
Q

prevention of HPV infection

A

HPV vaccines, using condoms all the time, cervical cancer screening, not smoking or quitting smoking

113
Q

risk factors for acquiring cervical CA

A

HPV infection accounts for most cases, having HIV d/t immune compromise, smoking, using birth control pills for more than 5 years, multiple partners

114
Q

When should paps be performed

A

Start at age 21

Screen every 3 years age 21 to 30

Use cytology only, do not test for HPV.

Screen more frequently if high risk, includes women who: have HIV, (at dx test q 6 months x 2, then annually if wnl) are immunosuppressed, were exposed to diethylstilbestrol (DES) in utero, or have been treated for high grade precancerous cervical lesion or cervical cancer

115
Q

Follow-up of normal pap or ASCUS based on results of HPV testing

A

HPV genotype for all women over 30

High risk HPV 16 and 18 and NILM - refer to colposcopy

HPV not high risk - repeat PAP & HPV in 12 months

116
Q

NILM

A

negative for intraepithelial lesion or malignancy

117
Q

ASC-US management under 30

A

atypical squamous cells of undetermined significance aged 21-24 - repeat cytology in 12 months if repeats is ASC-H, AGC or HSIL, perform colposcopy, otherwise repeat cytology in 12 months if repeat cytology at 24 months is negative, resume routine screening, otherwise perform colposcopy.

Alternative, perform HPV testing, if positive, repeat cytology in 12 months as above, if negative, resume routine screening

118
Q

ASC-H

A

atypical cells that cannot exclude high grade squamous intraepithelial cell lesions - always perform colposcopy regardless of HPV status

119
Q

LGSIL

A

Low grade squamous intraepithelial lesions - include HPV, mild dysphasia and CIN 1 Aged 25 or older, perform colposcopy, if HPV contesting was performed and neg, repeat cosseting in 1 year Aged 21-24 - repeat cytology in 12 and 24 months, follow guidelines for ASC-US

120
Q

HGSIL

A

high grade squamous intraepithelial lesions, include moderate to severe dysplasia, carcinoma in site, CIN2 and CIN 3. Colposcopy regardless of age, and likely immediate loop electrosurgical excision (LEEP) or endocervical curettage (ECC) (unless pregnant)

121
Q

AGC

A

atypical glandular cells - must specify endocervical, endometrial, or NOS refer to colposcopy with endocervical sampling, if over 35 also do endometrial sampling

122
Q

AIS

A

endocervical adenocarcinoma in situ

123
Q

preconception counseling list

A

Medications, OTC meds, herbal remedies Educate re teratogenic agents: environmental exposures/etoh/drugs Decrease caffeine to less than 200 mg day

Seafood recommendations ……Do not have Shark, king mackerel, tile fish, swordfish (these fish are high in mercury)

Folic acid -400 mcg/day supplements to prevent neural tube defects–

Vitamin D Weight management –

Ideal BMI 19.8 -26.0, exercise Both under and overweight is concerning

Medical Issues DM, PKU, Asthma, Thyroid, Seizures, SLE, Depression Labs –

rubella/ varicella titres, Hep bSag,, CBC, HIV, STD’s Detailed 3 generation (or more) Family History Heritable Disease– refer genetic counseling

124
Q

Management of women age 30 or older who are pap negative but HPV positive

A

repeat cytology and HPV testing in 12 months if cytology neg, HPV negative, repeat co-testing Q3 years if cytology ban. with any HPV result, follow cytology guidelines if cytology negative, HPV positive, perform colposcopy

125
Q

NonRx Prevention of Osteoporosis

A

Adequate Calcium, Vitamin D and regular exercise (weight bearing and muscle strengthening)

Eating foods rich in CA at least 1200mg per day Vit D 400 to 800 IU per day

Low-fat dairy products Dark green leafy vegetables Canned salmon or sardines with bones Soy products, such as tofu Calcium-fortified cereals and orange juice

126
Q

Breast Cancer Screening Recommendations USPSTF

A

USPSTF Age 50 to 74: Biennial mammograms

Age 40 to 49: Individualized decision re: biennial mammograms Age 75 and older: Insufficient evidence to make a recommendation re: mammograms Do not recommend monthly self breast exams (SBE) Insufficient evidence to recommend clinical breast exams (CBE)

Any risk breast cancer? Start annual mammogram at age 40

127
Q

Discussing and considering screening for breast CA

A

Using guidelines individualize discussion Any risks: start screening age 35 to 40 Age 40 discuss screening options Continue to offer mammogram screening at age 40, advise re possibility of false positives Teach SBE and breast awareness??? Do CBE annually????? High Risk – use guidelines, consider referral

128
Q

ovarian CA screening

A

No effective screening exists – screening not recommended Screening has not proven to decrease the death rate from the disease

Use pelvic U/S for adnexal masses Use CA-125, a tumor marker, for postmenopausal women with an adnexal mass or for detecting relapse Consider annual trans-vaginal pelvic ultrasound with CA-125 in high risk post menopausal women

129
Q

Depression Screening

A

Rarely is depression the chief complaint

Often associated with vague somatic complaints and with anxiety. May present with irritability and anger, feelings of helplessness and hopelessness, Loss of interest in daily activities, Appetite or wt changes Sleep changes, self loathing, reckless behavior, concentration problems, unexplained aches and pains

No universal screening for depression, but PHQ2 and PHQ9 are useful

130
Q

Presentation of MI in Women

A

About half of women with an MI present with chest pain.

More likely atypical symptoms: fatigue, sleep disturbance, shortness of breath, back pain, upper abdominal/epigastric pain, nausea with or without vomiting Less likely to identify their signs and symptoms as those of a heart attack.

Nonchest-pain symptoms may be falsely identified as non-cardiac. Average delay for treatment: 1 hour longer than men

131
Q

Definition of COPD

A

Chronic obstructive pulmonary disease (COPD) is a lung disease characterized by chronic obstruction of lung airflow that interferes with normal breathing and is not fully reversible.

The more familiar terms ‘chronic bronchitis’ and ‘emphysema’ are no longer used, but are now included within the COPD diagnosis.

COPD is not simply a “smoker’s cough” but an under-diagnosed, life-threatening lung disease

132
Q

Osteoporosis screening in Men

A

Screen men over 70 Consider screening younger men at high risk Guidelines differ –

USPSTF- insufficient evidence

National Osteoporosis Foundation – age 50 if high risk

American College of Preventitive Medicine – before 65 if high risk, evidence unclear

Screening test is: Central Bone Density Dual energy x -ray absorbitometry ( DXA)

133
Q

Osteoporosis Risk factors in Men

A

Low body weight

Hypogonadism

Hyperthyroidism

Previous fractures

Smoking

Check Vitamin D, assess calcium intake, advise weight bearing exercise

134
Q

T Scores Osteoporosis

A

Osteoporosis - T score <-2.5%

Osteopenia - T score between -1.0% and -2.5%

135
Q

cervical cancer screening in HIV+

A

Perform screening at Dx

test Q6mos x2

then annually if abnormal